Affiliation:
1. MRIGlobal, 425 Dr. Martin Luther King Jr. Blvd, Kansas City, MO 64110, USA
2. MRIGlobal, 65 West Watkins Mill Road, Gaithersburg, MD 20850, USA
Abstract
Rapid, specific, and sensitive identification of microbial pathogens is critical to infectious disease diagnosis and surveillance. Classical culture-based methods can be applied to a broad range of pathogens but have long turnaround times. Molecular methods, such as PCR, are time-effective but are not comprehensive and may not detect novel strains. Metagenomic shotgun next-generation sequencing (NGS) promises specific identification and characterization of any pathogen (viruses, bacteria, fungi, and protozoa) in a less biased way. Despite its great potential, NGS has yet to be widely adopted by clinical microbiology laboratories due in part to the absence of standardized workflows. Here, we describe a sample-to-answer workflow called PanGIA (Pan-Genomics for Infectious Agents) that includes simplified, standardized wet-lab procedures and data analysis with an easy-to-use bioinformatics tool. PanGIA is an end-to-end, multi-use workflow that can be used for pathogen detection and related applications, such as biosurveillance and biothreat detection. We performed a comprehensive survey and assessment of current, commercially available wet-lab technologies and open-source bioinformatics tools for each workflow component. The workflow includes total nucleic acid extraction from clinical human whole blood and environmental microbial forensic swabs as sample inputs, host nucleic acid depletion, dual DNA and RNA library preparation, shotgun sequencing on an Illumina MiSeq, and sequencing data analysis. The PanGIA workflow can be completed within 24 h and is currently compatible with bacteria and viruses. Here, we present data from the development and application of the clinical and environmental workflows, enabling the specific detection of pathogens associated with bloodstream infections and environmental biosurveillance, without the need for targeted assay development.
Funder
Defense Threat Reduction Agency—Joint Science and Technology Office for Chemical and Biological Defense
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Immunology and Microbiology
Reference35 articles.
1. Pricing infectious disease: The economic and health implications of infectious diseases;Fonkwo;EMBO Rep.,2008
2. Holmes, K.K., Bertozzi, S., and Bloom, B.R. (2023, January 23). Malaria Elimination and Eradication, Major Infectious Diseases, Available online: https://www.ncbi.nlm.nih.gov/books/NBK525190/.
3. WHO (2018). The Top 10 Causes of Death, WHO.
4. Emerging Infectious Diseases: A 10-Year Perspective from the National Institute of Allergy and Infectious Diseases;Fauci;Emerg. Infect. Dis.,2005
5. Positive Predictive Value of True Bacteremia according to the Number of Positive Culture Sets in Adult Patients;Kitaura;Yonago Acta Med.,2014
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献